Log In
person
Roivant Sciences Ltd
ROIV
summarize
2 total product lines
calendar_month
Revenue as of 03/31/2024
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Diversified Pre-Revenue Pharmaceuticals |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
75.06M | 60.14% |
| Diversified Pre-Revenue Pharmaceuticals |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
49.74M | 39.86% |
| keyboard_arrow_down |
Diversified Pre-Revenue Pharmaceuticals
Branded Pharmaceuticals (outsourced)
|
75.06M | 60.14% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Diversified Pre-Revenue Pharmaceuticals
Pre-Revenue Pharmaceuticals
|
49.74M | 39.86% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||